Linerixibat

Item number	Size	Delivery time	Price
TGM-T3978-1mg	1 mg	7 - 10 business days*	76.00€
TGM-T3978-2mg	2 mg	7 - 10 business days*	120.00€
TGM-T3978-5mg	5 mg	7 - 10 business days*	221.00€
TGM-T3978-1mL	1 ml	7 - 10 business days*	267.00€
TGM-T3978-10mg	10 mg	7 - 10 business days*	371.00€
TGM-T3978-25mg	25 mg	7 - 10 business days*	641.00€
TGM-T3978-50mg	50 mg	7 - 10 business days*	914.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50:... more

Close menu

Product information "Linerixibat"

Description: Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50: 42 ± 3 nM) that can lower glucose in an animal model of type 2 diabetes and demonstrates excellent developability properties. Target: HBV. Smiles: CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(O)=O)CC(O)=O)c(OC)cc2[C@H](N1)c1ccccc1. References: Nunez DJ, et al. Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. Diabetes Obes Metab. 2016 Jul,18(7):654-62.

Keywords:	Iinerixibat, GSK2330672
Supplier:	TargetMol
Supplier-Nr:	T3978

Properties

Application:	Targets solute carrier family 10 (sodium/bile acid cotransporter), member 2 (SLC10A2, ASBT)
MW:	546.68 D
Formula:	C28H38N2O7S
Format:	32160405

Database Information

CAS :	1345982-69-5\| Matching products
KEGG ID :	K14342 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Linerixibat"

Write a review